Knockoff is now live!
Filter out the knockoff crap brands on Amazon.
Sorry to brands like WNPETHOME, EHEYCIGA, YXYL, LU&MN, JOYIN, TOMY, GODONLIF, YOOJEE, LINGTENG, LANEIGE, VISCOO, BIODANCE, COOFANDY, BALENNZ, TOSY and LUENX.
https://t.co/9mLk0EAsfG
SpaceX IPO will be the most hyped trap for retail investors in a generation. By the time retail investors eagerly line up to buy shares, VCs and insiders will have already made 100x. Retail will be buying their exit at a massive 350B valuation. Another red flag is the way that SpaceX has structured its IPO lockup with a series of staggered release dates that allow most insiders to sell portions of their stock well before the standard 180-day window closes. Insiders sell. Price drops. Retail holds the bag. Are you ready for 6 months of selling pressure? The pattern is always the same retail buys the dream, insiders cash the cheque. SpaceX may be a great company. That doesn't make it a great stock at IPO price. I will wait the 6 months, read the earnings, then maybe buy the business, not the hype. I might miss out but that's a risk I'm comfortable with. You do you.
@MMKingT Thank you, Tracy! In my book, the best way to ascertain the standard of care is to ask what people are standardly doing with their care 💪
and @gjmccaughan helped us a ton with making this possible!!
in life, and specifically your career, there are opportunities that come with varying degrees of risk. they’re sliding door moments. it’s your responsibility to spot them and be brave enough to take them.
not making decisions because of comfort or fear IS making a decision.
ALLG member-doctors have delivered a striking letter to the New Zealand Prime Minister pointing out the stark reality of worse outcomes for Kiwis with blood cancer. This letter proposes immediate actions to address this unmet need - https://t.co/DFkrdeUnek.
ALLG’s MDS05/D3 MESSAGE trial, led by A/Prof Anoop Enjeti, is evaluating a new oral treatment combination for transfusion-dependent MDS, a rare blood cancer with few treatment options. It aims to reduce transfusion dependence, improve survival & enhance quality of life.
Glofitamab Combined With Pola-R-CHP or R-CHOP as First Therapy in Younger Patients With High-Risk Large B-Cell Lymphoma: Results From the COALITION Study
https://t.co/EsiMOKTJg8
Authored by @AdrianMinson, @mike_dickinson1, et al. #lymsm
Here's a zero-gravity parody song about this week's coverage of #BlueOrigin's rocket launch. Sorry we forgot to turn the clicker off but we were more worried about getting the pitch (nearly) right. It's called "Flight from Earth" based on the anthemic #Firework by #KatyPerry 🎇🎶
🚀 Announcing the all new Wispr Flow — the best voice dictation experience for professionals.
Flow makes you 3x faster, whether you’re talking to AI, sending emails, messaging your team, writing code, or ending a toxic relationship.
Now on Mac and Windows.
🧵
This week's paper edition of @TheLancetHaem: a picture worth a thousand words that I hadn't seen before!
Great graphic by Van de Donk @AjaiChari@mvmateos summarizing all possible methods of bsAb failure in #MMsm and potential strategies to overcome.
https://t.co/mjlYtAmArj
@jeremyphoward I know you’re long gone from there, but I’ve been a paying fastmail customer for over 20 years! Thought you were a legend then, still do!